BELANTAMAB

UNII:	7M3UL8MR2Y
Formula:
Preferred Substance Name:	BELANTAMAB
GSRS Full Record:	7M3UL8MR2Y i

2061894-48-0
BELANTAMAB [INN]
BELANTAMAB [USAN]
BELANTAMAB [WHO-DD]
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17 (B-CELL MATURATION PROTEIN, ANTIGEN CD269))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-451) (HUMANIZED VH (HOMO SAPIENS IGHV1-69*06 (84%) (IGHD)-IGHJ4*01 (86%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG1*01 (122-451)) (224-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-33*01 (91%) IGKJ2*02 (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (230-230'':233-233'')-BISDISULFIDE
LMMUNOGLOBULIN G1, ANTI-(TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMANIZED MONOCLONAL GSK2857914 Y1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL GSK2857914 K-CHAIN, DIMER

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BELANTAMAB

Synonyms and Mappings

Resources